Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing
Marielle C. Young(Massachusetts General Hospital), Aleena Banerji(Massachusetts General Hospital), Chantal Lemoine(Massachusetts General Hospital), Julia Moore(Massachusetts General Hospital), Zara Suran(University of Chicago), Benjamin R. Slawski(Massachusetts General Hospital), Kimberly G. Blumenthal(Jacksonville College)
Cited by 0
Related Papers
Drug allergy: A 2022 practice parameter update
|Journal of Allergy and Clinical Immunology|2022|504
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis
|New England Journal of Medicine|2017|171
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|PEDIATRICS|2021|136
Diet and Sleep Physiology: Public Health and Clinical Implications
|Frontiers in Neurology|2017|117